Results Mixed on Merck's New Painkiller
14th Nov 2006, 00:35 GMT
The 1st published studies of Arcoxia, the drug that Merck &.
Results Mixed on Merck's New Painkiller related news:
- Docs Give Merck Painkiller Acroxia Mixed Reviews — FOXNews.com
- Results Mixed on Merck's New Painkiller — LancasterOnline - Health
- Results mixed on Merck's new painkiller (AP) — Yahoo! News: Health News
- Results mixed on Merck's new painkiller (Associated Press) — Yahoo! Health: Health News
- Results on Merck's new painkiller draw mixed reviews — azcentral.com | business
- Tests of new Merck painkiller criticized — baltimoresun.com - health & science
- Merck: New pain killer safer than Vioxx — Business and financial news - CNNMoney.com
- Merck says new drug is safer than Vioxx — Cardiology News from StratCenter.com
- Mixed reviews for Vioxx successor — MSNBC.com: Health
- Vioxx-Like Drug Gets Mixed Reviews — Dayton Daily News National Headlines
Latest news from Physician News News from StratCenter.com:
- Prescription Solutions' Program Helps Prevent Adverse Drug Reactions, a Significant Health Hazard Especially for the Elderly
- On The Go Receives $152,000 Hardware Upgrade Order From Growing Canadian Medical Facility
- New Survey Data Reveal Majority of Asthma Patients Remain Uncontrolled Based on Scores from the Asthma Control Test
- Compuware Covisint to Present Best Practices to Healthcare Executives at Gartner Healthcare Summit
- CMPMedica Unveils Specialty Search Engine for Medical Professionals
- Trans Fat Raises Cardiac Health Concerns
- Bradley Pharmaceuticals Reminds Stockholders of Q3 2006 Earnings Conference Call
- Aetna to Help Members Quit Tobacco with New Tobacco Cessation Program
- Memorial Healthcare System Rolling Out Sentillion's Single Sign-On Solution to 7,000 Users
- Merger Creates 1st Statewide Epilepsy Service Organization in FL